Similarly, in GC cells, CEACAM6 regulates EMT through the PI3K/Akt pathway, and treatment of CEACAM6 overexpressing cells with the PI3K inhibitor LY294002 can reverse the EMT process [41]. This evidence concerns the gene CEACAM6 and gastric cancer.